The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -67.51%. However, over the last six months, the performance has been stronger by -60.26%. The price of OGEN decreased -35.41% over the last 30 days. And in the last five days, it has fallen by -38.24%.
Oragenics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $2.52 on 08/13/24, while the lowest price for the same duration was marked at $0.13 on 05/30/25.
52-week price history of OGEN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Oragenics Inc’s current trading price is -95.24% away from its 52-week high, while its distance from the 52-week low is -4.76%. The stock’s price range during this period has varied between$0.13 and $2.52. The Oragenics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.35 million for the day, a figure considerably higher than their average daily volume of 0.42 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Oragenics Inc (OGEN) has experienced a quarterly decline of -58.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.58M and boasts a workforce of 3 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2434, with a change in price of -0.2248. Similarly, Oragenics Inc recorded 3,234,069 in trading volume during the last 100 days, posting a change of -65.20%.
OGEN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for OGEN stands at 18.21. Similarly, the long-term debt-to-equity ratio is also 0.00.
OGEN Stock Stochastic Average
Oragenics Inc’s raw stochastic average for the past 50 days is presently 6.29%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 9.52%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 10.33% and 25.03%, respectively.
